Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.85M | -49.68M | -59.50M | -79.49M | -121.23M |
| Total Depreciation and Amortization | 16.13M | 16.94M | 17.83M | 18.09M | 18.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.11M | 53.62M | 53.45M | 53.14M | 53.91M |
| Change in Net Operating Assets | -42.39M | -47.92M | -57.77M | -52.26M | -31.42M |
| Cash from Operations | -21.01M | -27.04M | -45.99M | -60.53M | -80.47M |
| Capital Expenditure | -3.03M | -2.50M | -2.96M | -2.40M | -2.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.28M | 24.02M | 40.91M | 70.72M | 58.66M |
| Cash from Investing | -25.30M | 21.52M | 37.95M | 68.32M | 56.33M |
| Total Debt Issued | 335.51M | -- | -- | -- | -- |
| Total Debt Repaid | -148.11M | -- | -- | -- | -- |
| Issuance of Common Stock | 36.22M | 32.45M | 30.40M | 8.87M | 7.23M |
| Repurchase of Common Stock | -25.00M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.60M | -- | -- | -- | -- |
| Cash from Financing | 173.03M | 32.45M | 30.40M | 8.87M | 7.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.72M | 26.93M | 22.37M | 16.66M | -16.92M |